Skip to content
Research Article Open access CC BY 3.0

Transfusion Transmissible Infections among Blood Donors at the Blood Bank of Medical College of Gwalior: A 5 Year Study

Dharmesh Chandra Sharma, Sunita Rai, Savita Bharat, Sudha Iyenger, Shruti Gupta, Satya Sao, Bharat Jain

International Blood Research & Reviews · pp. 235–246 · Published 16 Jun 2014

10.9734/IBRR/2014/11193

Abstract

Introduction: Transfusion Transmitted Infections (TTIs) are a major problem associated with blood transfusion. Accurate estimates of risk of TTIs are essential for monitoring the safety of blood supply and evaluating the efficacy of currently employed screening procedures. Aims: To determine the prevalence of transfusion transmitted infections among blood donors in greater Gwalior region and its surrounding areas i.e. central India and its comparison with other relevant studies. Place and Duration of Study: Study was carried out at Blood Bank, Department of Pathology, Gajra Raja Medical College, Gwalior, India from January 2009 to December 2013 (5 year study). Methodology: Total 67,123 blood units collected from blood donors were tested for transfusion transmitted infections (TTIs) i.e. HIV I & II, HBV, HCV,VDRL and Malaria parasite at Blood Bank as per guidelines of World Health Organization (WHO) for Asia Pacific region and Food and Drug Administration, Government of India. Results: Out of 67,123 blood units studied, voluntary units were 61309(91.3%) and replacement units were 5823 (8.7%). In the present study total TTIs positive units were 2747 (4.09%) (p=0.000005). Amongst them HBV were 2360 (3.51%) (p=0.000005), HIV positive units were 91(0.13%), HCV were 161 (0.24%), VDRL were 114 (0.17%) and Malaria 21 (0.03%). Conclusion: Our study concluded that amongst all the TTIs in the blood donors in Gwalior and its surrounding area, seroprevalence of HBV was significantly higher than other infections. It is also higher than similar studies conducted in other parts of India.  

Transfusion transmitted infections hepatitis B virus human immunodeficiency virus hepatitis C virus blood donors

References (31)

  1. 1 Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures [DOI]
  2. 2 The Risk of Transfusion-Transmitted Viral Infections [DOI]
  3. 3 Hepatitis C
  4. 4 Hepatitis B Virus Infection: Epidemiology and Vaccination [DOI]
  5. 5 Seroprevalence of human immunodeficiency virus, hepatitis B and C viruses and syphilis infections among blood donors at the Muhimbili National Hospital in Dar Es Salaam, Tanzania [DOI]
  6. 6 Frequency of HBV DNA detection in US blood donors testing positive for the presence of anti‐HBc: implications for transfusion transmission and donor screening [DOI]
  7. 7 Sero-epidemiology of transfusion-transmissible infectious diseases among blood donors in Osogbo, south-west Nigeria. [DOI]
  8. 8 Significant increase in HBV, HCV, HIV and syphilis infections among blood donors in West Bengal, Eastern India 2004-2005: Exploratory screening reveals high frequency of occult HBV infection [DOI]
  9. 9 Seroprevalence and Trends in Transfusion Transmitted Infections Among Blood Donors in a University Hospital Blood Bank: A 5 Year Study [DOI]
  10. 10 Prevalence and Trends of Markers of Hepatitis C Virus, Hepatitis B Virus and Human Immunodeficiency Virus in Delhi Blood Donors: A Hospital Based Study [DOI]
  11. 11 Seroprevalence and incidence of transfusion‐transmitted infectious diseases among blood donors from regional blood transfusion centres in Burkina Faso, West Africa [DOI]
  12. 12 Prevalence of Transfusion Transmitted Infections in Voluntary and Replacement Donors [DOI]
  13. 13 How safe are our safe donors?
  14. 14 Seroprevalence of transfusion transmissible infections among voluntary blood donors at a tertiary care teaching hospital in rural area of India [DOI]
  15. 15 Practical Transfusion Medicine [DOI]
  16. 16 Infectious Disease Markers in Blood Donors [DOI]
  17. 17 Relative prevalence of hepatitis B viral markers and hepatitis C virus antibodies (anti HCV) in Madurai, south India.
  18. 18 Viral hepatitis in Nigeria—sickle-cell disease and commercial blood donors [DOI]
  19. 19 Epidemiology of Hepatitis C Virus [DOI]
  20. 20 Seroprevalence of Hepatitis B, Hepatitis C, and human immunodeficiency virus among healthy voluntary first-time blood donors in Kolkata [DOI]
  21. 21 Prevalence of transfusion-associated viral infections and syphilis among blood donors in Muhimbili Medical Centre, Dar es Salaam, Tanzania.
  22. 22 Transfusion transmitted diseases [DOI]
  23. 23 Diagnosis of hepatitis B infections and monitoring of treatment [DOI]
  24. 24 Decreasing Prevalence of Transfusion Transmitted Infection in Indian Scenario [DOI]
  25. 25 HEPATITIS C VIRUS ANTIBODIES AMONG BLOOD DONORS IN JOS, NIGERIA
  26. 26 Seroprevalence of hepatitis C antibodies in healthy blood donors--a prospective study.
  27. 27 Decreasing risk of viral transfusion-transmitted diseases in Croatia.
  28. 28 Effectiveness of mandatory transmissible diseases screening in Indian blood donors.
  29. 29 Epidemiologic trends in infection, mortality, and transplants related to hepatitis C in Wisconsin.
  30. 30 Transfusion‐Transmitted Infections [DOI]
  31. 31 Seroprevalence of HIV, HBV, HCV and syphilis in voluntary blood donors.

Cited by 13

A DEMOGRAPHIC STUDY OF HEPATITIS B IN HEALTHY POPULATION OF CENTRAL INDIA

Gajendra Pal Singh Uike, Amar Bahadur Singh, Uday Raj Singh · Journal of Evolution of Medical and Dental Sciences · 2015

Reported Seroprevalence of Transfusion-Transmitted Infections in Voluntary and Replacement Donors

Ghulam Rasool, Arif Muhammad Khan, Imran Riaz Malik · Transfusion Medicine Reviews · 2023

Prevalence and burden of HBV co‐infection among people living with HIV: A global systematic review and meta‐analysis

Lucy Platt, Clare E. French, Catherine R. McGowan · Journal of Viral Hepatitis · 2019

Prevalence and trends of transfusion transmissible infections among blood donors in the State of Qatar, 2013–2017

Mohamed Aabdien, Nagah Selim, Sayed Himatt · BMC Infectious Diseases · 2020

Showing 5 of 13 known citations — external sources report more than can currently be individually listed.

Article metrics

Real usage data collected on this platform.

27

Page views

0

PDF downloads

3

Outbound clicks

13

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.